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A fluorescent analogue of 2-5A, ~QQS’~A~‘QS’~A~‘QS’~A, wasobtained by reaction of 2’,5’(pA), with 
chloroacetaldehyde followed by conversion to the 5-triphosphate through reaction of the corresponding 
phosphoroimidazolide with pyrophosphate anion. The 5’-monophosphate, pS’eA2’~5’42’pS’~A, was 
not an antagonist of 2-5A action in extracts of mouse L cells. Neither did the 5’-triphosphate, 
QQQ~‘~A~‘QS’~A~‘QS’~A, inhibit translation. Moreover, the 5’-triphosphate was bound to the 
2-SA-dependent endonuclease 5000-times less effectively than 2-5A itself. 
Interferon 2-5A 2-5A-Activated endonuclease Ethenoadenosine 
Fluorescence Oligonucleotide synthesis 
1. INTRODUCTION 
When certain vertebrate cell lines are treated with 
interferon, several new proteins are synthesized and 
a cellular antiviral state develops [l--3]. One newly 
induced protein is referred to as 2-SA synthetase 
which synthesizes, after activation by dsRNA, a 
unique 2’) 5 ‘-linked oligoadenylate, 2-5A [4]. This 
oligonucleotide may then activate a latent cellular 
endoribonuclease which can degrade mRNA, there- 
by preventing translation [l-3]. This 2-5A system, 
i.e., the 2-5A synthetase, 2-5A itself, and the 
2-SA-activated ribonuclease, may be the basis of 
interferon’s antiviral action, at least in the instance 
of several virus infections [5,6]. 
Fluorescent 1 ,N6-etheno analogues of adenine 
nucleotides and polynucleotides have been synthe- 
sized and found to be substrates in many enzyma- 
tic reactions [7 and references cited therein]. In the 
present context, a fluorescent analogue of 2-5A 
could be of value in studying the conformation 
and/or oligonucleotide-enzyme interactions of the 
2-SA-activated endonuclease and perhaps also the 
2-5A synthetase and 2-5A phosphodiesterase 
[l-3]. An earlier report [8] had suggested that 
6ATP was a substrate for 2-5A synthetase and that 
the resulting 2,5’pp(peA)s (2-5eA) was an efficient 
activator of the endonuclease. In order to confirm 
and extend these findings, and because of our 
interest in delineating the structural parameters in- 
volved in binding of 2-5A to the endonuclease [9], 
we have chemically synthesized 2’,5’(pcA)3 and 
2’,5’pp(p~A)3 and evaluated their interaction with 
the 2-SA-dependent endonuclease (also referred to 
as RNase L or F [l-3]). 
2. MATERIALS AND METHODS 
2.1. Spectroscopy 
Abbreviations: eA, 1, N6-ethenoadenosine i.e., (3- 
/3-D-ribofuranosylimidazo[2.1-ilpurine); 2’,5’(p~A)~, 
Q~‘EA~‘QS’~A~‘QS’~A; 2’,5’pp(p~A)3, QQQ~‘cA~‘QS’E- 
A2’pS’cA; 2-SA, QQQ~‘A~‘QS’(A~‘Q~‘),A, where 
n 2 l--10 
‘H-NMR spectra were recorded with a Varian 
HR220 instrument operating at 220 MHz. The sol- 
vent was DzO with dioxane (6 = 3.75 ppm from 
TMS) as an internal standard. Chemical shifts are 
reported as 6 in ppm. Multiplicity is abbreviated as 
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s (singlet), d (doublet) or m (multiplet). 31P-NMR 
spectra were obtained with a Varian instrument at 
109 MHz with DzO as solvent and 0.15% H3P04 
as external reference. 
The concentrations and quantities of etheno- 
adenosine in the products were determined with a 
Hewlett-Packard 8450 A UV/VIS spectrophoto- 
meter using the following values: ez5’ = 11.5. 10T3 
for 2’,5’(pA)3, ?5 = 4.5. 10m3 and ez5’ = 3.75. low3 
for 2’, 5’(pcrA)3. Calculations of the degree of modi- 
fication with tiA residues were based on a previous 
observation [lo] that the UV spectra of poly(eA,A) 
copolymers (3’,5’-linked) with varying ratios of 
the bases have two isosbestic points at 243.5 nm 
and at 280 nm. Thus, the degree of modification 
(or the % of l,N6-ethenoadenine residues) can be 
represented by the equation [lo]: 
(A258 - A294 ’ fl) 2fg + A294~ 
e(~.W3 
where: 
A = absorption at given wavelength 
ElwA)3 
The fluorescence mission spectra were recorded 
with a Perkin-Elmer MPF-44A Fluorescence spec- 
trophotometer. All measurements were done at 
room temperature in 0.1 M phosphate buffer 
(pH 7.2) and with the excitation wavelength 
305 nm. The apparent spectra were corrected and 
relative quantum efficiencies were determined 
according to the literature Ill]. For relative quan- 
tum efficiency determination, ethenoadenosine 
5’-monophosphate (P-L Biochemicals) was used as 
a reference compound, quantum efficiency 0.59 
1121. 
2.2. Thin-layer chromatography 
Thin-layer chromatography was performed on 
E. Merck precoated PEI-cellulose F plates with 
solvent systems: (A) 0.1 M NH4HC03; (B) 0.25 M 
NH4HC03; or (C) 1 M LiCl; or on cellulose F 
plates with system D, 1 M ammonium acetate 
(pH 4.9) CH3OH (1:2). 
2.3. l,N6-ethenoadenylyl(2 ‘- >5 I)-i,N6-etheno- 
adenylyI(2’->5 I)-I,N6-ethenoadenosine 
5 ~-~onopho~phate~2 ‘, 5 ‘(pA)3] 
The oligomer, 2’,5’(~A)~ (2850 Am units, 0.083 
mmol, prepared as in [13]) was dissolved in 10% 
chloroacetaldehyde solution (3 ml, 3.8 mmol, 71: 
1.3375, prepared from dimethylacetal as in [12]) 
and the solution’s pH was adjusted to 4.9 with 1 M 
sodium acetate (pH 4.3). After 48 h incubation at 
37”C, 90% of the adenine residues had reacted 
according to calculations made from the UV spec- 
trum of the crude mixture (vide ante). The reaction 
mixture then was applied to a DEAE Sephadex 
A-25 (HCO;) column (1.6 x 35 cm), and elution 
was performed with a linear gradient of 0.05-0.5 M 
triethylammonium bicarbonate buffer (pH 7.5). 
Two partly overlapping fractions were collected. 
The first (450 A275 units, 40%) contained oligo- 
adenylate with 96% of the adenosine residues con- 
verted to ethenoadenosine, and the second fraction 
contained oligomer with 89% of the adenosine con- 
verted to ethenoadenosine as determined by UV 
spectroscopy (vide ante). This first fraction there- 
fore is referred to as 2’,5’(pcA)~. On TLC, 
2’,5’(peA)3 ran as a single spot with Rf’s of 0.38 
(system A), 0.67 (system C) and 0.13 (system D). 
“P-NMR: 6 1_62ppm, s, 1P; 6 -1.11 ppm, s, 2P. 
‘H-NMR: 6 5.72 ppm (d, J-C 2 Hz, 1H); 65.93 ppm 
(d, J<2 Hz, 1H); S 6.05 ppm (d, J<2 Hz, 1H); 
6 6.85 (s, 1H); 6 7.13 (s, 1H); S 7.30 (s, IH); 6 7.38 
(s, 1H); 6 8.53 (s, 1H); S 8.60 (s, 1H). 
Relative fluorescence quantum efficiency: 0.05 1. 
2.4. 1,N6-ethenoadenylyl(2’->5’)-1,N6-etheno- 
adenylyl(2 I- >5 o-1, N6-ethenoadenosine 
5 I-triphosphate [2’,5 ‘pp(pfA)3 /
An aqueous solution of 2’,5’(pcA)3 (240 Am 
units, 0.018 mmol) was evaporated to dryness and 
was then dried by two consecutive additions and 
evaporations of dry DMF (2 x 2 ml). Gentle war- 
ming was necessary to dissolve the residue. DMF 
(1 ml) and carbonyl diimidazole (30 mg, 0.19 mmol) 
were then added, and the mixture was stirred at 
ambient temperature for 1 h. The reaction mixture 
was poured into a solution of sodium iodide in 
acetone (20 ml of 1070 solution), and the precipitate 
of sodium salt of the 5’-phosphoroimidazolide of 
2’,5’(peA)3 that formed, was centrifuged down, 
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washed several times with acetone and then dried 2.5. Cell-free protein synthesis and radiobinding 
in vacua. assays 
Di-(tri-~-butylammonium)-pyrophosphate (250~1 
of 0.5 M in DMF) was added to the dried phos- 
phoroimidazolide and the mixture was kept at 
room temperature for 24 h after which it was di- 
luted with cold water (1 ml) and applied to a column 
of DEAE-Sephadex (A-25, HCO?, 1 x 10 cm). 
Elution was with a linear gradient of triethyl- 
ammonium bicarbonate (0.3-0.6 M, 400 ml total). 
The yield was 78 oD275 units (6 pmol, 33%). The 
product, pp(p~A)3, was homogeneous by TLC in 
solvent systems B (Rf = 0.42) and C (Rr = 0.14). 
These were performed as in [14-151. The radio- 
activeprobeppp5~A2’p5iA2’p5fA3’[3zP]p5’C3’p, 
was obtained from Amersham and had a specific 
activity of 3000 Ci/mmol. 
3. RESULTS AND DISCUSSION 
31PNMR:S-1.04(s, lP)and-1.14(s, lP);ci-7.07 
(d, J=20.0Hz, P,); 6 -11.55 (d, J= 19.3 Hz, 
P,); 6 -22.70 (m, J = 20.0 Hz, PD). 
‘H-NMR: 6 8.78 (s, 1H); S 8.73 (s, 1H); S 8.22 
(s, 1H); S 8.15 (s, 1H); S 7.99 (s, 1H); 6 7.88 
(s, IH); 6 7.55 (s, 2H); 6 7.27 (s, 1H); 6 7.13 
(s, 1H); 6 6.95 (s, IH); S 6.15 (d, J c 2 Hz, 1H); 
S6.09(d,J<2Hz, lH);65.89(d, J<2 Hz, 1H). 
Relative fluorescence quantum efficiency: 0.063. 
The 5’-monophosphorylated analogue, 2’,5’(pA)s 
was prepared in 4Ovo yield by the reaction of 
2’,5’(pA)3 with aqueous chloroacetaldehyde solu- 
tion under conditions similar to those in [12,17]. A 
product was obtained which, by UV spectroscopic 
estimates, consisted of at least 96~0 ethenoadeno- 
sine residues with no more than 4% adenosine resi- 
dues. This estimate was confirmed by ‘H-NMR 
which revealed, in addition to the 3 anomeric pro- 
tons, a total of 12 aromatic protons corresponding 
to 6 from the purine ring system and 6 from the 
etheno substitution. Integration of the PMR spec- 
trum indicated complete replacement of the adeno- 
sine residues with ethenoadenosine. 31P-NMR 
Fig.la. Ability of 2’,5’(p~A)~ (0) or 2’,5’(pA)3 (0) to prevent the protein synthesis inhibitory action of 2-5A. In these 
experiments, the concentration of 2%5A was constant at 2.10-s M, and the concentration of the oligonucleotide mono- 
phosphate varied. 100% corresponds to the level of protein synthesis obtained in the absence of any additions. The 
appropriate controls also included the effect of addition of 2’,5’(peA)3 (A) alone and the effect of addition of 2’,5’(pA)3 
alone (A). 
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revealed the obligatory internucleotide and 5’- 
monophosphate phosphorus resonances. This 
monophosphate was transformed, using standard 
procedures, to the corresponding 5’-triphosphate, 
2’,5’pp(pfA)3, the structure of which was con- 
firmed by 31P and ‘I-I-NMR. 
It has been demonstrated [15] that the 5’-mono- 
phosphate, 2’,5’(p&, is an antagonist of 2-5A 
action since it can bind to the 2-SA-dependent 
nuclease and displace 2-5A itself. This pheno- 
menon has been used to ascertain the ability of 
various 5’-monophosphates to interact with the 
endonuclease [9]. Under conditions where 10m6 M 
2’,5’(pA)3 was able to prevent 50% of the protein 
synthesis, inhibitory action of 2-5A, 2’,5’(p~A)3 
did not reveal any significant antagonistic effect 
even at 10F4 M (fig. la), suggesting that its affinity 
for the endonuclease must be at least 60-times less 
than that of 2-5A. In agreement with this finding, 
when 2’,5’pp(peA)3 was evaluated as an inhibitor 
of translation in encephalomyocarditis virus RNA- 
programmed extracts of mouse L cells, it was 
found to be devoid of activity; i.e., it did not cause 
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significant inhibition of translation at low4 M, 
whereas 2-5A itself gave 50% of maximum pro- 
tein synthesis inhibition at 10m9 M (fig. lb). Finally, 
pp(pc’A)3 was checked for its ability to bind to the 
2-SA-dependent endonuclease using the radio- 
active assay in [16]. The fluorescent analogue, 
pp(peA)3, was bound at least SOL-times less effec- 
tively than 2-5A as judged by the ability of such 
ligands to displace the probe ppp5’A2’p5’A2’pSf- 
A2’p5’A3’[32P]p5’C3’p from the endonuclease 
(fig. lc). 
In contrast o an earlier report [8] which provided 
no verification of the structure of the purported 
2’,5’pp(peA), product, we have found that 
2’,5’pp(peA)3 binds very poorly to the 2-5A- 
dependent endoribonuclease and cannot give rise 
to inhibition of protein synthesis even at concen- 
trations of lo5 M that are necessary to inhibit 
translation in the case of 2-5A action. These re- 
sults indicate that the etheno modification, altering 
as it does the N’ and N6 sites of the purine ring, 
is not compatible with binding to the 2-SA-depen- 
dent endonuclease. Consistent with this, other 
i OLlGOMER 
Fig.lb. Ability of the 5’-triphosphate pp(peA)3 to inhibit protein synthesis in extracts of mouse L cells programmed 
by encephalomyocarditis virus RNA. 100% protein synthesis represents the level of translation in the absence of any 
additions. The effect of addition of varying quantities of 2’,5’pp(peA)s (0) is compared to the effect of addition of 
varying amounts of 2’,5’pp(pA)3 (0). 
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Fig.lc. Ability of 2’,5’pp(~eA)~ (0) and 2’,5’(pA)3 (e) to bind to the 2-SA-activated endonuclease of L cells as 
ascertained by the radiobinding assay in [16]. Increasing amounts of 2’ ,5’ pp(peA), or 2’ ,S’pp(pA)3 were added to a 
constant concentration of the probe ppp5’A2’p5’A2’pS’A2’p5’A3’-[32P]p5’C3’p in a buffer containing extracts of 
mouse L cells 1161. 
studies in this laboratory [9 and, Lesiak, Sawai and 
Torrence, unpublished observations], have shown 
that repI;cernent of the adenine ring with uracil, 
cytosine, or inosine gives analogues with greatly 
reduced affinity for the endonuclease. It appears, 
therefore, that determinants of the adenine ring 
are vital in the interaction of 2-SA with the 2-5A- 
dependent endonuclease. 
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